SCHEMBL6557593

SCHEMBL6557593

NC(=O)C(C(=O)NCC(=O)CNS(=O)(=O)c1ccccc1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.41
CTSK P43235 2/20 0.41
CTSS P25774 1/20 0.41
MMP1 P03956 3/20 0.40
MMP12 P39900 2/20 0.40
GAA P10253 1/20 0.40
PRMT1 Q99873 1/20 0.40
CASP1 P29466 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP14 P50281 2/20 0.38
ADAM17 P78536 2/20 0.38
ADAMTS4 O75173 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
MMP8 P22894 1/20 0.38
MEP1B Q16820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5440673 0.80 LARS1 (0.41) KEAP1CTSKCTSSMMP1MMP12
SCHEMBL5471723 0.78 PRMT1 (0.40) KEAP1CTSKCTSSMMP1MMP12
SCHEMBL7551628 0.75 CTSS (0.49) CTSKCTSS
SCHEMBL2969958 0.70 MMP1 (0.59) KEAP1MMP1MMP12GAAPRMT1
SCHEMBL6557583 0.68 SLC1A3 (0.37) MMP1ALDH1A1MMP2MMP9MMP13
SCHEMBL13758640 0.67 HSD11B1 (0.56) KEAP1MMP1MMP12GAAALDH1A1
SCHEMBL6560207 0.67 GRM7 (0.37) MMP1ALDH1A1MMP2MMP9MMP13
SCHEMBL14378293 0.67 MMP1 (0.51) KEAP1MMP1MMP12GAAALDH1A1
SCHEMBL7366406 0.67 ALDH1A1 (0.56) KEAP1MMP1MMP12GAAALDH1A1
SCHEMBL359770 0.66 MMP1 (0.79) MMP1MMP12GAAALDH1A1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO claimed